Zymeworks Stock (NASDAQ: ZYME) stock price, news, charts, stock research, profile.
Open | $9.280 |
Close | $8.810 |
Volume / Avg. | 985.858K / 617.238K |
Day Range | 8.640 - 9.280 |
52 Wk Range | 6.015 - 13.140 |
Market Cap | $622.910M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 8.11% |
Days to Cover | 9.45 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Zymeworks (NASDAQ: ZYME) through any online brokerage.
Other companies in Zymeworks’s space includes: Cabaletta Bio (NASDAQ:CABA), Cogent Biosciences (NASDAQ:COGT), Sage Therapeutics (NASDAQ:SAGE), CareDx (NASDAQ:CDNA) and Pharming (NASDAQ:PHAR).
The latest price target for Zymeworks (NASDAQ: ZYME) was reported by HC Wainwright & Co. on Tuesday, May 7, 2024. The analyst firm set a price target for 10.00 expecting ZYME to rise to within 12 months (a possible 13.51% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Zymeworks (NASDAQ: ZYME) is $8.81 last updated May 10, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Zymeworks.
Zymeworks’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Zymeworks.
Zymeworks is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.